Tele-patient-reported Outcomes (telePRO) in Clinical Practice - Effect of Patient-initiated Versus Fixed Interval telePRO Based Outpatient Follow-up
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Epilepsy
- Sponsor
- University of Aarhus
- Enrollment
- 593
- Locations
- 1
- Primary Endpoint
- Number of contacts
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The aim of this study is to compare quality of care and patient experiences in two outpatients follow-up activities: 1) Standard telePRO (fixed interval telePRO follow-up) and 2) Open Access telePRO (patient-initiated telePRO follow-up)
Detailed Description
The traditional system of routine outpatient follow-up of chronic disease in secondary care may involve a waste of resources if patients are well. The use of patient-reported outcomes (PRO) could support more flexible, cost-saving follow-up activities. AmbuFlex is a PRO system used in outpatient follow-up in the Central Denmark Region. PRO questionnaires are sent to patients at fixed intervals. The clinicians use the PRO data to decide whether a patient needs a visit or not (standard telePRO). PRO may make patients become more involved in their own care pathway, which may improve their self-management. Better self-management may also be achieved by letting patients initiate contact. The aim of this study is to obtain data on the effects of patient-initiated follow-up (open access telePRO) on resource utilisation, quality of care, and the patient perspective.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males and females from Age 15 years
- •Diagnosis of epilepsy
- •Referred to standard telePRO by a clinician
- •Access to internet (web-responders in standard telePRO)
- •Can speak and understand Danish
Exclusion Criteria
- •Paper responders
- •Referred to telePRO proxy questionnaire
Outcomes
Primary Outcomes
Number of contacts
Time Frame: 18 months
Number of contacts includes all contacts with the outpatient clinic in the study follow-up period
Secondary Outcomes
- Mortality(18 months)
- Health literacy will be assessed by The Health Literacy Questionnaire (sub scale 4, 6, and 9)(18 months)
- Self-efficacy will be assessed by The General Self-Efficacy Scale(18 months)
- Safety will be assessed by one item from the Danish Cancer Society PREM (Barometer) Questionnaire(18 months)
- General health will be assessed by items from the SF-36 questionnaire(18 months)
- Well-being wil be assessed by the WHO-5 Well-being Index(18 months)
- Number of seizures(18 months)
- Confidence will be assessed by one item from the Danish Cancer Society PREM (Barometer) Questionnaire(18 months)
- Side effects(18 months)
- Satisfaction will be assessed by one item from the Danish Cancer Society PREM (Barometer) Questionnaire(18 months)